XML 47 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
Basis Of Presentation And Consolidation (Tables)
6 Months Ended
Mar. 31, 2014
Basis Of Presentation And Consolidation [Abstract]  
Schedule Of Corrections

The following table summarizes the impact of the restatement on net income (loss) and diluted net income (loss) per share attributed to Landauer, Inc. for the three and six months ended March 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Dollars in Thousands, Except per Share Amounts)

 

Three Months Ended
March 31, 2014
(Unaudited)

 

Six Months Ended
March 31, 2014
(Unaudited)

 

 

Net Income (Loss)

 

Diluted Net Income (Loss) Per Share

 

Net Income (Loss)

 

Diluted Net Income (Loss) Per Share

As previously reported

 

$

4,997 

 

$

0.52 

 

$

8,048 

 

$

0.84 

Revenue and accounts receivable

 

 

(500)

 

 

 

 

 

(248)

 

 

 

Dosimetry devices

 

 

13 

 

 

 

 

 

25 

 

 

 

Long-term investments

 

 

(25)

 

 

 

 

 

54 

 

 

 

Sales taxes

 

 

(16)

 

 

 

 

 

(32)

 

 

 

Intangible assets

 

 

 -

 

 

 

 

 

150 

 

 

 

Equity in joint ventures

 

 

 -

 

 

 

 

 

708 

 

 

 

Total adjustments

 

 

(528)

 

 

(0.05)

 

 

657 

 

 

0.07 

Income tax expense (benefit)

 

 

(41)

 

 

 -

 

 

362 

 

 

0.04 

Less amounts attributed to noncontrolling interest

 

 

(4)

 

 

 -

 

 

 

 

 -

Net impact of adjustments

 

 

(483)

 

 

(0.05)

 

 

287 

 

 

0.03 

As restated

 

$

4,514 

 

$

0.47 

 

$

8,335 

 

$

0.87 

 

The effect of the restatement on the previously issued Consolidated Statement of Operations for the three and six months ended March 31, 2014 is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
March 31, 2014
(Unaudited)

 

Six Months Ended
March 31, 2014
(Unaudited)

(Dollars in Thousands, Except per Share)

 

Previously Reported

 

As Restated

 

Previously Reported

 

As Restated

Service revenues

 

$

32,983 

 

$

32,870 

 

$

64,877 

 

$

64,615 

Product revenues

 

 

6,571 

 

 

6,184 

 

 

12,382 

 

 

12,586 

Net revenues

 

 

39,554 

 

 

39,054 

 

 

77,259 

 

 

77,201 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Service costs

 

 

15,195 

 

 

15,155 

 

 

30,244 

 

 

30,165 

Product costs

 

 

3,150 

 

 

3,177 

 

 

6,308 

 

 

6,552 

Total cost of sales

 

 

18,345 

 

 

18,332 

 

 

36,552 

 

 

36,717 

Gross profit

 

 

21,209 

 

 

20,722 

 

 

40,707 

 

 

40,484 

Selling, general, and administrative

 

 

13,735 

 

 

13,750 

 

 

28,097 

 

 

27,976 

Acquisition, reorganization and nonrecurring costs

 

 

109 

 

 

109 

 

 

220 

 

 

220 

Operating income

 

 

7,365 

 

 

6,863 

 

 

12,390 

 

 

12,288 

Equity in income of joint ventures

 

 

535 

 

 

535 

 

 

1,108 

 

 

1,816 

Interest expense, net

 

 

(975)

 

 

(1,014)

 

 

(1,867)

 

 

(1,951)

Other income (expense), net

 

 

(8)

 

 

 

 

29 

 

 

164 

Income before taxes

 

 

6,917 

 

 

6,389 

 

 

11,660 

 

 

12,317 

Income tax (benefit) expense

 

 

1,954 

 

 

1,913 

 

 

3,450 

 

 

3,812 

Net income

 

 

4,963 

 

 

4,476 

 

 

8,210 

 

 

8,505 

Less:  Net income attributed to noncontrolling interest

 

 

(34)

 

 

(38)

 

 

162 

 

 

170 

Net income attributed to Landauer, Inc.

 

 

4,997 

 

 

4,514 

 

 

8,048 

 

 

8,335 

Net income per share attributed to Landauer, Inc. shareholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

0.52 

 

 

0.47 

 

 

0.84 

 

 

0.87 

Weighted average basic shares outstanding

 

 

9,460 

 

 

9,460 

 

 

9,441 

 

 

9,441 

Diluted

 

 

0.52 

 

 

0.47 

 

 

0.84 

 

 

0.87 

Weighted average diluted shares outstanding

 

 

9,501 

 

 

9,501 

 

 

9,485 

 

 

9,485 

 

The effect of the restatement on the previously issued Consolidated Statement of Cash Flows for the six months ended March 31, 2014 is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended
March 31, 2014
(Unaudited) (a)

(Dollars in Thousands)

 

Previously Reported

 

As Restated

Cash flows provided from operating activities:

 

 

 

 

 

 

Net income

 

 

8,210 

 

 

8,505 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

7,662 

 

 

7,487 

Gain on investments

 

 

(203)

 

 

(338)

Equity in income of joint ventures

 

 

(1,108)

 

 

(1,816)

Dividends from joint ventures

 

 

1,340 

 

 

1,340 

Stock-based compensation and related net tax benefits

 

 

453 

 

 

453 

Current and long-term deferred taxes, net

 

 

791 

 

 

847 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Decrease in accounts receivable, net

 

 

3,119 

 

 

3,205 

Decrease in prepaid taxes

 

 

721 

 

 

1,027 

Decrease in other operating assets, net

 

 

571 

 

 

761 

Decrease in accounts payable and other accrued liabilities

 

 

(2,025)

 

 

(2,021)

Increase in other operating liabilities, net

 

 

430 

 

 

430 

Net cash provided by operating activities

 

 

19,961 

 

 

19,880 

Cash flows used by investing activities:

 

 

 

 

 

 

Acquisition of property, plant & equipment

 

 

(2,415)

 

 

(2,415)

Acquisition of joint ventures and businesses, net of cash acquired

 

 

(1,800)

 

 

(1,800)

Other investing activities, net

 

 

(637)

 

 

(114)

Net cash used by investing activities

 

 

(4,852)

 

 

(4,329)

Cash flows (used) provided by financing activities:

 

 

 

 

 

 

Net borrowings on revolving credit facility

 

 

(43)

 

 

(43)

Long–term borrowings - loan

 

 

20,000 

 

 

20,000 

Long–term borrowings - repayment

 

 

(24,500)

 

 

(24,500)

Dividends paid to stockholders

 

 

(10,520)

 

 

(10,520)

Other financing activities, net

 

 

(347)

 

 

(347)

Net cash used by financing activities

 

 

(15,410)

 

 

(15,410)

Effects of foreign currency translation

 

 

108 

 

 

109 

Net (decrease) increase in cash and cash equivalents

 

 

(193)

 

 

250 

Opening balance – cash and cash equivalents

 

 

11,184 

 

 

8,672 

Ending balance – cash and cash equivalents

 

 

10,991 

 

 

8,922 

 

(a)

As reported in the Company's 2014 third fiscal quarter Form 10-Q (filed on August 11, 2014), certain errors were identified in the Consolidated Statement of Cash Flows that impacted prior periods.  The errors related to the following:   treatment of accrued additions for property, plant and equipment, classification of debt financing fees and classification of unrealized gains or losses on investments in the Consolidated Statements of Cash Flows.   The prior period consolidated statements of cash flows were revised in the 2014 third fiscal quarter Form 10-Q to correct for these errors and the impacts of the corrections are reflected within the 'Previously Reported' columns above.